Citizens Raises OptimizeRX (OPRX) PT to $23 on Subscription Growth, Margin Potential
Tweet Send to a Friend
Citizens analyst Constantine Davides raised the price target on OptimizeRX (NASDAQ: OPRX) to $23.00 (from $20.00) while maintaining a Market ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
